de Abreu Murilo S, Giacomini Ana C V V, Echevarria David J, Kalueff Allan V
Bioscience Institute, University of Passo Fundo (UPF), Passo Fundo, RS, Brazil; The International Zebrafish Neuroscience Research Consortium (ZNRC), Slidell, LA, USA.
Bioscience Institute, University of Passo Fundo (UPF), Passo Fundo, RS, Brazil; Postgraduate Program in Environmental Sciences, University of Passo Fundo (UPF), Passo Fundo, Brazil.
Regul Toxicol Pharmacol. 2019 Feb;101:65-70. doi: 10.1016/j.yrtph.2018.11.007. Epub 2018 Nov 16.
Despite the growing emphasis on translational neuropharmacology and drug discovery research, the legality underlying these fields are seldom considered. The zebrafish (Danio rerio) is an increasingly utilized model organism in neuropharmacology and neurotoxicology. As the acceptance of zebrafish in biomedicine continues to grow, the legal aspects of their applications remain outpaced by this exponential growth. Therefore, there is a need to evaluate the legal aspects of zebrafish applications to CNS drug research. Here, we discuss a wide range of regulatory topics relevant to zebrafish research, such as the bioethics of experimentation (including studies of stress and pain), welfare protection laws, the recent advances in CNS drug discovery, and specific legal aspects of controlled substance research in this aquatic species. The conceptualization and understanding of the zebrafish welfare and its promise as a model in toxicology can also potentially shape environmental protection practices and inform policy making.
尽管人们越来越重视转化神经药理学和药物发现研究,但这些领域背后的合法性却很少被考虑。斑马鱼(Danio rerio)在神经药理学和神经毒理学中越来越多地被用作模式生物。随着斑马鱼在生物医学中的认可度不断提高,其应用的法律方面仍跟不上这种指数级增长的步伐。因此,有必要评估斑马鱼应用于中枢神经系统药物研究的法律方面。在这里,我们讨论了与斑马鱼研究相关的广泛监管主题,例如实验的生物伦理学(包括应激和疼痛研究)、福利保护法、中枢神经系统药物发现的最新进展以及该水生物种中受控物质研究的具体法律方面。斑马鱼福利的概念化和理解以及它作为毒理学模型的前景也可能会塑造环境保护实践并为政策制定提供参考。